STUDY QUESTION Is there any methylome alteration in women with PCOS who were
diagnosed using the new international evidence-based guidelines? SUMMARY ANSWER A …

Polycystic ovary syndrome (PCOS) is often associated with aberrant DNA methylation.
Despite the advances in diagnostics and treatment of PCOS, the pathophysiological …

Objective To compare genome-wide DNA methylation profiles in ovary tissue from women
with polycystic ovary syndrome (PCOS) and healthy controls. Design Case-control study …

As a universally common endocrinopathy in women of reproductive age, the polycystic
ovarian syndrome is characterized by composite clinical phenotypes reflecting the …

Polycystic ovary syndrome (PCOS) is one of the most common endocrine disorders in
women. However, the epigenetic mechanism involved in PCOS progression remains largely …

Background: Polycystic ovary syndrome (PCOS) is a common endocrine disease in women
that seriously interferes with patient's metabolic and reproductive functions. The current …

Background: Polycystic ovary syndrome (PCOS), a common endocrine disorder affecting 5%–
10% of reproductive age women worldwide, associated with various metabolic morbidities …

Purpose Polycystic ovary syndrome (PCOS) is an endocrine metabolic disease that affects
women of reproductive age and is one of the main causes of anovulatory infertility. However …

The present study aimed to identify potentially important biomarkers associated with
polycystic ovary syndrome (PCOS) by integrating DNA methylation with transcriptome …

Purpose This study aimed to identify differentially methylated genes (DMGs) and
differentially expressed genes (DEGs) to investigate new biomarkers for the diagnosis and …